|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||









* Partners AIDS Research Center and Infectious Disease Division, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114;
Childrens Hospital, Boston, MA 02115;
Nuffield Department of Medicine, John Radcliffe Hospital, Oxford, United Kingdom;
Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115; ¶ Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital, Perth, Australia; || Boston Medical Center, Boston, MA 02118;# Queen Elizabeth Hospital, Bridgetown, Barbados; and ** National Cancer Institute, HIV and AIDS Malignancy Branch, Bethesda, MD 20892
Mutational escape from the CTL response represents a major driving force for viral diversification in HIV-1-infected adults, but escape during infancy has not been described previously. We studied the immune response of perinatally infected children to an epitope (B57-TW10) that is targeted early during acute HIV-1 infection in adults expressing HLA-B57 and rapidly mutates under this selection pressure. Viral sequencing revealed the universal presence of escape mutations within TW10 among B57- and B5801-positive children. Mutations in TW10 and other B57-restricted epitopes arose early following perinatal infection of B57-positive children born to B57-negative mothers. Surprisingly, the majority of B57/5801-positive children exhibited a robust response to the TW10 escape variant while recognizing the wild-type epitope weakly or not at all. These data demonstrate that children, even during the first years of life, are able to mount functional immune responses of sufficient potency to drive immune escape. Moreover, our data suggest that the consequences of immune escape may differ during infancy because most children mount a strong variant-specific immune response following escape, which is rarely seen in adults. Taken together, these findings indicate that the developing immune system of children may exhibit greater plasticity in responding to a continually evolving chronic viral infection.
This article has been cited by other articles:
![]() |
L. R. McKinnon, R. Capina, H. Peters, M. Mendoza, J. Kimani, C. Wachihi, A. Kariri, M. Kimani, M. Richmond, S. K. Kiazyk, et al. Clade-Specific Evolution Mediated by HLA-B*57/5801 in Human Immunodeficiency Virus Type 1 Clade A1 p24 J. Virol., December 1, 2009; 83(23): 12636 - 12642. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Thobakgale, A. Prendergast, H. Crawford, N. Mkhwanazi, D. Ramduth, S. Reddy, C. Molina, Z. Mncube, A. Leslie, J. Prado, et al. Impact of HLA in Mother and Child on Disease Progression of Pediatric Human Immunodeficiency Virus Type 1 Infection J. Virol., October 1, 2009; 83(19): 10234 - 10244. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Schneidewind, Y. Tang, M. A. Brockman, E. G. Ryland, J. Dunkley-Thompson, J. C. Steel-Duncan, M. A. St. John, J. A. Conrad, S. A. Kalams, F. Noel, et al. Maternal Transmission of Human Immunodeficiency Virus Escape Mutations Subverts HLA-B57 Immunodominance but Facilitates Viral Control in the Haploidentical Infant J. Virol., September 1, 2009; 83(17): 8616 - 8627. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Crawford, W. Lumm, A. Leslie, M. Schaefer, D. Boeras, J. G. Prado, J. Tang, P. Farmer, T. Ndung'u, S. Lakhi, et al. Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipients J. Exp. Med., April 13, 2009; 206(4): 909 - 921. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Miura, C. J. Brumme, M. A. Brockman, Z. L. Brumme, F. Pereyra, B. L. Block, A. Trocha, M. John, S. Mallal, P. R. Harrigan, et al. HLA-Associated Viral Mutations Are Common in Human Immunodeficiency Virus Type 1 Elite Controllers J. Virol., April 1, 2009; 83(7): 3407 - 3412. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Miura, M. A. Brockman, A. Schneidewind, M. Lobritz, F. Pereyra, A. Rathod, B. L. Block, Z. L. Brumme, C. J. Brumme, B. Baker, et al. HLA-B57/B*5801 Human Immunodeficiency Virus Type 1 Elite Controllers Select for Rare Gag Variants Associated with Reduced Viral Replication Capacity and Strong Cytotoxic T-Lymphotye Recognition J. Virol., March 15, 2009; 83(6): 2743 - 2755. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Bailey, T. P. Brennan, K. A. O'Connell, R. F. Siliciano, and J. N. Blankson Evidence of CD8+ T-Cell-Mediated Selective Pressure on Human Immunodeficiency Virus Type 1 nef in HLA-B*57+ Elite Suppressors J. Virol., January 1, 2009; 83(1): 88 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. L. Brumme, C. J. Brumme, J. Carlson, H. Streeck, M. John, Q. Eichbaum, B. L. Block, B. Baker, C. Kadie, M. Markowitz, et al. Marked Epitope- and Allele-Specific Differences in Rates of Mutation in Human Immunodeficiency Type 1 (HIV-1) Gag, Pol, and Nef Cytotoxic T-Lymphocyte Epitopes in Acute/Early HIV-1 Infection J. Virol., September 15, 2008; 82(18): 9216 - 9227. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Streeck, B. Li, A. F.Y. Poon, A. Schneidewind, A. D. Gladden, K. A. Power, D. Daskalakis, S. Bazner, R. Zuniga, C. Brander, et al. Immune-driven recombination and loss of control after HIV superinfection J. Exp. Med., August 4, 2008; 205(8): 1789 - 1796. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Maness, L. J. Yant, C. Chung, J. T. Loffredo, T. C. Friedrich, S. M. Piaskowski, J. Furlott, G. E. May, T. Soma, E. J. Leon, et al. Comprehensive Immunological Evaluation Reveals Surprisingly Few Differences between Elite Controller and Progressor Mamu-B*17-Positive Simian Immunodeficiency Virus-Infected Rhesus Macaques J. Virol., June 1, 2008; 82(11): 5245 - 5254. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Thobakgale, D. Ramduth, S. Reddy, N. Mkhwanazi, C. de Pierres, E. Moodley, W. Mphatswe, N. Blanckenberg, A. Cengimbo, A. Prendergast, et al. Human Immunodeficiency Virus-Specific CD8+ T-Cell Activity Is Detectable from Birth in the Majority of In Utero-Infected Infants J. Virol., December 1, 2007; 81(23): 12775 - 12784. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ueno, Y. Idegami, C. Motozono, S. Oka, and M. Takiguchi Altering Effects of Antigenic Variations in HIV-1 on Antiviral Effectiveness of HIV-Specific CTLs J. Immunol., May 1, 2007; 178(9): 5513 - 5523. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gros, M. Pelegrin, M. Plays, and M. Piechaczyk Efficient Mother-to-Child Transfer of Antiretroviral Immunity in the Context of Preclinical Monoclonal Antibody-Based Immunotherapy. J. Virol., October 1, 2006; 80(20): 10191 - 10200. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Bailey, T. M. Williams, R. F. Siliciano, and J. N. Blankson Maintenance of viral suppression in HIV-1-infected HLA-B*57+ elite suppressors despite CTL escape mutations J. Exp. Med., May 15, 2006; 203(5): 1357 - 1369. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhang, J. Fu, Q. Zhao, Y. He, L. Jin, H. Zhang, J. Yao, L. Zhang, and F.-S. Wang Differential Restoration of Myeloid and Plasmacytoid Dendritic Cells in HIV-1-Infected Children after Treatment with Highly Active Antiretroviral Therapy J. Immunol., May 1, 2006; 176(9): 5644 - 5651. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Martinez-Picado, J. G. Prado, E. E. Fry, K. Pfafferott, A. Leslie, S. Chetty, C. Thobakgale, I. Honeyborne, H. Crawford, P. Matthews, et al. Fitness Cost of Escape Mutations in p24 Gag in Association with Control of Human Immunodeficiency Virus Type 1. J. Virol., April 1, 2006; 80(7): 3617 - 3623. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. O'Connor and D. R. Burton Immune responses and HIV: a little order from the chaos J. Exp. Med., March 20, 2006; 203(3): 501 - 503. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |